The DOI matches its Crossref record; 133 of the 135 references it cites were found in a registry or an index.
Cancer nanotechnology: opportunities and challenges
Abstract
Nanotechnology is a multidisciplinary field, which covers a vast and diverse array of devices derived from engineering, biology, physics and chemistry. These devices include nanovectors for the targeted delivery of anticancer drugs and imaging contrast agents. Nanowires and nanocantilever arrays are among the leading approaches under development for the early detection of precancerous and malignant lesions from biological fluids. These and other nanodevices can provide essential breakthroughs in the fight against cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Targeted therapy is thus the combination of targeted delivery with sustained drug release, which allows the maximum utilization of the drug delivered at the tumor site.236”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [236]
Citations
Cites
Helical microtubules of graphitic carbon
Iijima, S. (1991) · Nature · doi:10.1038/354056a0 · Cited by 43,126
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Semiconductor Clusters, Nanocrystals, and Quantum Dots
Alivisatos, A. P. (1996) · Science · doi:10.1126/science.271.5251.933 · Cited by 11,518
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Nanotube Molecular Wires as Chemical Sensors
Kong, J., Franklin, N., Zhou, C., Chapline, M. G., Peng, S., Cho, K., & Dai, H. (2000) · Science · doi:10.1126/science.287.5453.622 · Cited by 6,046
Nanowire Nanosensors for Highly Sensitive and Selective Detection of Biological and Chemical Species
Cui, Y., Wei, Q., Park, H., & Lieber, C. M. (2001) · Science · doi:10.1126/science.1062711 · Cited by 5,857
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
Hirsch, L. R., Stafford, R. J., Bankson, J. A., Sershen, S. R., Rivera, B., Price, R. E., Hazle, J. D., Halas, N. J., & West, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232479100 · Cited by 3,961
A New Class of Polymers: Starburst-Dendritic Macromolecules
Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G. J., Martin, S., Roeck, J., Ryder, J., & Smith, P. B. (1985) · Polymer Journal · doi:10.1295/polymj.17.117 · Cited by 3,908
Probing the Cytotoxicity of Semiconductor Quantum Dots
Derfus, A. M., Chan, W. C. W., & Bhatia, S. N. (2003) · Nano Letters · doi:10.1021/nl0347334 · Cited by 3,394
Flagged first, then by citations
2 of the 135 references couldn’t be matched to a known paper.
Research works printed but not linked: 7
- Decuzzi, P., Lee, S., Bhushan, B. & Ferrari, M. Non-specific interaction of nanoparticles as drug delivery and nanoharvesting agents within the vasculature. Ann. Biomed. Eng. (in the press). Mathematical models drive the design of nanovectors for optimal use in therapeutics and diagnostics.
- Ferrari, M. Therapeutic microdevices and methods of making and using same. US Patent 6,107,102 (2000). Early investigation of multifunctional drug-delivery nanosystems.
- Hayflick, L. Mortality and immortality at the cellular level. Biochemistry 62, 1180–1190 (1997).
- Matsumura, Y. & Maeda H. A new concept for macromolecular therapies in cancer chemotherapy: mechanisms of tumortropic accumulation of proteins and the antitumor agents SMANCS. Cancer Res. 6, 6397–6392 (1986).
- Sel, Y. N. et al. Comparison of vascular permeability and enzymatic activation of the polymeric prodrug HPMA copolymer–doxorubicin (PK1) in human tumor xenografts. Proc. Am. Assoc. Cancer Res. 90, 41 (1999).
- Wu, J., Akaka, T. & Maeda, H. Modulation of enhanced permeability in tumor by a bradykinine antagonist, a cyclooxygenase inhibitor. Cancer Res. 58, 159–165 (1998).
- Ferrari, M. et al. Particles for oral delivery of peptides and proteins. US Patent 6,355,270 (2002).
Cited by
Sorted by citations
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Drug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,854
The golden age: gold nanoparticles for biomedicine
Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., & El‐Sayed, M. A. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15237h · Cited by 3,659
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,443
Metadata
- Authors
- Ferrari, M.
- Venue
- Nature Reviews Cancer
- Published
- 2005-03-01
- Volume
- 5
- Issue
- 3
- Pages
- 161-171
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1989195046
- Cited by
- 4,558
- References
- 135
- Citations by year
- 2026: 60 · 2025: 99 · 2024: 137 · 2023: 181 · 2022: 157 · 2021: 191 · 2020: 221 · 2019: 240 · 2018: 257 · 2017: 291 · 2016: 287 · 2015: 297 · 2014: 328 · 2013: 367 · 2012: 294
- FWCI
- 13.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › General Materials Science › Nanotechnology research and applications
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- cancer nanotechnology, nanovectors, targeted drug delivery, anticancer agents, imaging contrast agents, nanowires, early cancer detection, precancerous lesions, biological fluids
- MeSH terms
- Antineoplastic Agents, Contrast Media, Diagnosis, Differential, Equipment Design, Humans, Neoplasms, Nanotechnology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
